[Other antimicrobials (linezolid, quinupristin/dalfopristin)].
Yamaguchi
Keizo
K
Department of Microbiology, Toho University School of Medicine.
Ohno
Akira
A
D000081:Acetamides / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D001426:Bacterial Proteins / Q000096:biosynthesis; D003864:Depression, Chemical; D024901:Drug Resistance, Multiple, Bacterial; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000378:metabolism; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D000069349:Linezolid; D023303:Oxazolidinones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D014769:Virginiamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology
D000081:Acetamides; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D023303:Oxazolidinones; D014769:Virginiamycin; C113825:quinupristin; D000069349:Linezolid; C113826:dalfopristin